Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,000 | 64,000 | 70,330 | 57,993 | 58,497 |
| Marketable Securities | 6,000 | 14,000 | 5,070 | 22,316 | 22,051 |
| Receivables | 361,000 | 445,000 | 537,780 | 413,838 | 298,886 |
| Inventories | 354,000 | 376,000 | 461,980 | 386,742 | 226,213 |
| Income taxes - deferred | 152,000 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 156,000 | 191,460 | 183,132 | 143,231 |
| TOTAL | $992,000 | $1,055,000 | $1,266,620 | $1,064,021 | $748,878 |
| Non-Current Assets | |||||
| PPE Net | 567,000 | 604,000 | 679,880 | 498,967 | 347,186 |
| Investments And Advances | 99,000 | 55,000 | 34,050 | 66,239 | 77,890 |
| Intangibles | 1,671,000 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 98,000 | 1,858,000 | 1,912,130 | 338,580 | 338,174 |
| TOTAL | $2,435,000 | $2,517,000 | $2,626,060 | $903,786 | $763,250 |
| Total Assets | $3,427,000 | $3,572,000 | $3,892,710 | $1,967,807 | $1,512,128 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 67,000 | 92,000 | 108,590 | 98,878 | 64,453 |
| Accrued Expenses | 352,000 | 318,000 | 316,250 | 229,594 | 131,951 |
| Other current liabilities | 3,000 | 3,000 | 148,500 | 6,292 | 1,929 |
| TOTAL | $819,000 | $1,055,000 | $1,619,650 | $808,011 | $463,823 |
| Non-Current Liabilities | |||||
| Long Term Debt | 574,000 | 678,000 | 1,363,820 | 46,325 | 0 |
| Other Non-Current Liabilities | 99,000 | 115,000 | 88,090 | 69,205 | 72,059 |
| TOTAL | $673,000 | $793,000 | $1,451,910 | $173,564 | $132,034 |
| Total Liabilities | $1,492,000 | $1,848,000 | $3,071,570 | $981,575 | $595,857 |
| Shareholders' Equity | |||||
| Common Shares | 4,000 | 4,000 | 3,940 | 1,956 | 1,791 |
| Retained earnings | 1,116,000 | 752,000 | 381,240 | 706,542 | 585,057 |
| Other shareholders' equity | -113,000 | -116,000 | -70,800 | -58,822 | -27,544 |
| TOTAL | $1,935,000 | $1,724,000 | $821,130 | $986,232 | $916,271 |
| Total Liabilities And Equity | $3,427,000 | $3,572,000 | $3,892,700 | $1,967,807 | $1,512,128 |